Format
Items per page
Sort by

Send to:

Choose Destination

Links from

Items: 1 to 20 of 111

1.

Effects of psychoactive substances in schizophrenia -- findings of structural and functional neuroimaging.

Walter M, Denier N, Vogel M, Lang UE.

Curr Top Med Chem. 2012;12(21):2426-33. Review.

PMID:
23279181
2.

Cannabis abuse is associated with better emotional memory in schizophrenia: a functional magnetic resonance imaging study.

Bourque J, Mendrek A, Durand M, Lakis N, Lipp O, Stip E, Lalonde P, Grignon S, Potvin S.

Psychiatry Res. 2013 Oct 30;214(1):24-32. doi: 10.1016/j.pscychresns.2013.05.012. Epub 2013 Jul 30.

PMID:
23906663
3.

Impulsivity-related brain volume deficits in schizophrenia-addiction comorbidity.

Schiffer B, Müller BW, Scherbaum N, Forsting M, Wiltfang J, Leygraf N, Gizewski ER.

Brain. 2010 Oct;133(10):3093-103. doi: 10.1093/brain/awq153. Epub 2010 Jul 20.

4.

Comorbid substance use disorder in schizophrenia: a selective overview of neurobiological and cognitive underpinnings.

Thoma P, Daum I.

Psychiatry Clin Neurosci. 2013 Sep;67(6):367-83. doi: 10.1111/pcn.12072. Epub 2013 Jul 25. Review.

5.

[Cannabis and schizophrenia: demographic and clinical correlates].

Dervaux A, Laqueille X, Bourdel MC, Leborgne MH, Olié JP, Lôo H, Krebs MO.

Encephale. 2003 Jan-Feb;29(1):11-7. French.

PMID:
12640322
6.

Cannabis abuse and brain morphology in schizophrenia: a review of the available evidence.

Malchow B, Hasan A, Fusar-Poli P, Schmitt A, Falkai P, Wobrock T.

Eur Arch Psychiatry Clin Neurosci. 2013 Feb;263(1):3-13. doi: 10.1007/s00406-012-0346-3. Epub 2012 Aug 21. Review.

7.

[Schizophrenia and addiction: An evaluation of the self-medication hypothesis].

Potvin S, Stip E, Roy JY.

Encephale. 2003 May-Jun;29(3 Pt 1):193-203. Review. French.

PMID:
12876543
8.

Quetiapine in patients with comorbid schizophrenia-spectrum and substance use disorders: an open-label trial.

Potvin S, Stip E, Lipp O, Elie R, Mancini-Marië A, Demers MF, Roy MA, Bouchard RH, Gendron A.

Curr Med Res Opin. 2006 Jul;22(7):1277-85.

PMID:
16834826
9.
10.

[Neuroimaging in substance abuse disorders].

de Mendelssohn A, Kasper S, Tauscher J.

Nervenarzt. 2004 Jul;75(7):651-62. Review. German.

PMID:
15300321
11.
12.

Relationship between comorbidity and violence risk assessment in forensic psychiatry - the implication of neuroimaging studies.

Palijan TZ, Radeljak S, Kovac M, Kovacević D.

Psychiatr Danub. 2010 Jun;22(2):253-6. Review.

13.

Cannabis, vulnerability, and the onset of schizophrenia: an epidemiological perspective.

Hambrecht M, Häfner H.

Aust N Z J Psychiatry. 2000 Jun;34(3):468-75.

PMID:
10881971
14.

Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia.

Ho BC, Andreasen NC, Ziebell S, Pierson R, Magnotta V.

Arch Gen Psychiatry. 2011 Feb;68(2):128-37. doi: 10.1001/archgenpsychiatry.2010.199.

15.

[Acting out and psychoactive substances: alcohol, drugs, illicit substances].

Gillet C, Polard E, Mauduit N, Allain H.

Encephale. 2001 Jul-Aug;27(4):351-9. Review. French.

PMID:
11686057
16.

Differential impact of heavy cannabis use on sensory gating in schizophrenic patients and otherwise healthy controls.

Rentzsch J, Penzhorn A, Kernbichler K, Plöckl D, Gómez-Carrillo de Castro A, Gallinat J, Jockers-Scherübl MC.

Exp Neurol. 2007 May;205(1):241-9. Epub 2007 Feb 21.

PMID:
17368620
17.

The vulnerability to alcohol and substance abuse in individuals diagnosed with schizophrenia.

Krystal JH, D'Souza DC, Gallinat J, Driesen N, Abi-Dargham A, Petrakis I, Heinz A, Pearlson G.

Neurotox Res. 2006 Dec;10(3-4):235-52. Review.

PMID:
17197373
18.

Adequate antipsychotic treatment normalizes serum nerve growth factor concentrations in schizophrenia with and without cannabis or additional substance abuse.

Jockers-Scherübl MC, Rentzsch J, Danker-Hopfe H, Radzei N, Schürer F, Bahri S, Hellweg R.

Neurosci Lett. 2006 Jun 12;400(3):262-6. Epub 2006 Mar 15.

PMID:
16540246
19.

Progressive structural brain abnormalities and their relationship to clinical outcome: a longitudinal magnetic resonance imaging study early in schizophrenia.

Ho BC, Andreasen NC, Nopoulos P, Arndt S, Magnotta V, Flaum M.

Arch Gen Psychiatry. 2003 Jun;60(6):585-94.

PMID:
12796222
20.

The impact of alcohol dependence on social brain function.

Gizewski ER, Müller BW, Scherbaum N, Lieb B, Forsting M, Wiltfang J, Leygraf N, Schiffer B.

Addict Biol. 2013 Jan;18(1):109-20. doi: 10.1111/j.1369-1600.2012.00437.x. Epub 2012 Feb 17.

PMID:
22340281
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk